Copyright
©The Author(s) 2021.
World J Gastrointest Surg. Sep 27, 2021; 13(9): 1063-1078
Published online Sep 27, 2021. doi: 10.4240/wjgs.v13.i9.1063
Published online Sep 27, 2021. doi: 10.4240/wjgs.v13.i9.1063
Ref. | Methodology | Technique | n | Age | Follow-up | Diagnosis and Assessment | Outcome | Complications |
Ellis[32], 2010 (United States) | Retrospective cohort | TPI [porcine intestinal submucosal collagen implant (Surgisis®)] ± SP | 32 (entire cohort n = 120) | 58.7 ± 8.9 | 12 mo | BBUSQ-22 | Improvement of BBUSQ-22 individual items (total improvement 30.9%): Significant improvement (decline) in 6 items | Urine retention (n = 2), Recurrence (n = 0) |
Significant deterioration (raise) in pain with bowel movements | ||||||||
Non-significant changes in 2 items | ||||||||
Smart and Mercer-Jones[33], 2007 (United Kingdom) | Prospective case series | TPI [porcine dermal collagen implant (Permacol®)]> Suction drain (last 8 patients) | 10 | 51, median (33-71) | 9 mo, median (5-16) | Watson score | All patients (100%) had improvement in 2 or more symptoms, and 70% in three or more | Hematoma (n = 2) |
Decline of Watson score (Pre = 10.5, PO = 4.5) | ||||||||
Hirst et al[29], 2005 (United Kingdom) | Retrospective cohort | TPR + LP + Implant | 7 (entire cohort n = 82) | 51, median (25-83) | NP | Clinical assessment | Surgery outcome: cured (n = 5 patient), initial improvement (n = 1 patient), no improvement (n = 1 patient), further surgery (n = 2 patient); Satisfaction: n = 6 patient | Mesh erosion (n = 1); Recurrence (n = 1) |
Mercer-Jones et al[34], 2004 (United Kingdom) | Retrospective case series | TPI ± SPProlene mesh (n = 14),Prolene + PGA mesh [Vypro II®] (n = 8) | 22 | 53, median (28-66) | 12.5 mo (3.0-47.0) | Watson score | Decline in Watson score (Pre = 11.1, PO = 3.9); Significant (P < 0.05) symptomatic improvement (n = 20 patient) | Wound infection (n = 2), wound infection and dehiscence (n = 1), dyspareunia (n = 1) Recurrence (n = 1) |
Subjective outcome (P < 0.05) in favor of Vypro II® mesh: Moderate to excellent [Prolene (n = 9 patient), Vypro II® (n = 8 patient)] | ||||||||
Poor [prolene (n = 5 patient), Vypro II® (n = 0 patient)] | ||||||||
Azanjac and Jorovic[35], 1999 (Serbia) | Prospective case series | TPI [prolene mesh (Atrium®)] | 6 | 56 (46-68) | 11 mo (7-18) | Symptom assessment; Satisfaction assessment | Successful rectal evacuation without digitation (n = 6 patient); Symptom improvement [markedly (n = 2 patient), completely (n = 4 patient)] | Urine retention (n = 1) |
Satisfaction [very satisfied (n = 5 patient), somewhat (n = 1 patient)] | ||||||||
Watson et al[36], 1996 (United Kingdom) | Prospective case series | TPR + LP + Implant [prolene mesh (Marlex®)] | 9 | 50, median (32-61) | 29 mo, median (8-36) | Watson scoreFluoroscopic defecography | Significant decline in PO score (Pre = 11.7, PO = 1.9, P < 0.05); No further need for digital evacuation (n = 8); Significant decline in rectocele depth (Pre = 3.7, PO = 2.4, P < 0.05) | Wound infection (n = 1); Dyspareunia: Resolved (n = 1), abstained (n = 2), acquired (n = 1) |
Significant decline in barium trapping (Pre = 14%, PO = 5%, P < 0.005) |
- Citation: Fathy M, Elfallal AH, Emile SH. Literature review of the outcome of and methods used to improve transperineal repair of rectocele. World J Gastrointest Surg 2021; 13(9): 1063-1078
- URL: https://www.wjgnet.com/1948-9366/full/v13/i9/1063.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v13.i9.1063